News
-
WuXi PharmaTech And PRA Form Joint Venture To Offer Clinical Research Services For Chinese Market
12/18/2012
WuXi PharmaTech, a leading contract research organization with operations in China and the United States, and PRA, a leading global clinical contract research organization, recently announced that they have signed a joint venture agreement to offer a broad platform of Phase I-IV clinical trial services in China, Hong Kong and Macau.
This website uses cookies to ensure you get the best experience on our website. Learn more